MOSS BEACH, Calif.--(BUSINESS WIRE)--BioMedEcon, a leading provider of health economics and outcomes research, announces that Cheryl Hankin, Ph.D., president and chief scientific officer, has been appointed to the external advisory committee for the Boston University School of Public Health’s Center for the Assessment of Pharmaceutical Practices (CAPP) and Pharmaceutical Assessment Management and Policy (PAMP). The CAPP and PAMP programs are directed by Dr. Lewis Kazis, professor of Health Policy and Management at the Boston University School of Public Health.
